Key facts
- What it is
- Growing and condition-specific. Clinical studies and extensive practice experience report benefits, while certainty varies by outcome.
- Typical course
- There is no evidence-based standard course. Agree goals and a review point before booking multiple sessions.
- Cost per session
- Prices vary substantially by country, setting, and practitioner; ask about the full cost before treatment.
- Who it may suit
- People considering it as an optional complement, not a replacement for appropriate medical assessment and care.
- Safety profile
- Published trials report few serious adverse events, but reporting is limited. Check the medical red flags below.
Depression and low mood are remarkably common — affecting hundreds of millions of people globally. The most evidence-based treatments are psychotherapy and antidepressant medication. Craniosacral therapy is not a treatment for clinical depression, but some people with depression and anxiety report that CST helps them feel more settled, less anxious, and more present in their bodies. The nervous system regulation aspect of CST may be relevant for people whose depression involves a dysregulated stress response.
How craniosacral therapy helps
In a CST session where the main reason for coming in is low mood or feeling stuck, the work is gentle, non-directive, and clothing-on. You remain fully clothed on a treatment table; the pressure is very light (often described as 5 grams - the weight of a small coin). The work is directed at the bones, sutures, and membranous attachments of the cranium and sacrum, at the diaphragms (thoracic, pelvic, and the soft palate / cranial diaphragm), and at the fascial continuity that connects the spine, the thoracic inlet, the respiratory diaphragm, the jaw, and the pelvic floor. None of this is positioned as 'treating depression' - depression is not a single mechanism, and CST addresses some of the felt experience of low mood and some of the underlying drivers of the autonomic dysregulation, sleep disturbance, and chronic tension that often accompany low mood rather than the depression itself.
What the practitioner is listening for and working with: the underlying CST model, drawn from the cranial and fascial literature, holds that sustained low mood, anhedonia, social withdrawal, disrupted sleep, the felt sense of heaviness, and patterns of held tension can leave restrictions at the cranial base, the suboccipital region, the thoracic inlet, the diaphragm, the sacrum, the dural tube, and especially the jaw and the shoulders, that show up as the body staying in a low-arousal but high-tension state - heavy, contracted, breathing shallowly, difficulty initiating sleep or waking unrefreshed, the jaw or shoulders holding what the mind cannot put down. A practitioner experienced in working with low mood will also ask about: full medical history including any recent infections or post-viral illness; full mental health history including any prior depressive episodes, anxiety, trauma, or substance use; the current pattern of low mood - how long it has been present, whether it is constant or comes in waves, whether anything in particular triggers or relieves it; sleep pattern (timing, duration, waking, daytime energy); appetite and weight change; caffeine, alcohol, nicotine, and substance use; current medications including any recent changes; hormonal cycle and perimenopause where relevant, and any recent pregnancy, miscarriage, or postpartum period; work, social, and relationship stressors; what has already been tried (psychological therapy, CBT, medication, mindfulness, breathwork, exercise programmes, lifestyle changes); and any cardiac, respiratory, neurological, thyroid, or pain symptoms that might be driving the picture. A careful practitioner will not position CST as a substitute for the psychological and medical assessment or for psychotherapy and/or SSRI/SNRI where a depressive disorder is suspected, and will be alert to the differential - bipolar depression, postnatal depression, perimenopausal depression, PMDD, seasonal affective disorder, depression secondary to a medical condition - and will refer back to the primary care physician and mental health professional as needed.
Why some people find CST useful for the felt experience of low mood and why it is not a stand-alone fix: the indirect argument for CST is that many of the felt drivers of low mood - overactive autonomic arousal in some patterns and a heavy low-arousal shutdown in others, chronic muscle tension, shallow breathing, disrupted sleep-wake cycles, difficulty resting, and the felt sense of disconnection from the body - are the kinds of things that gentle, sustained, non-directive manual work can plausibly help with. Several CST studies (described in the evidence summary) have measured mood and quality of life as primary or secondary outcomes and found improvements, including in fibromyalgia trials where depression scores dropped significantly. The honest read: CST is one optional complementary input for some of the underlying drivers of the felt experience of low mood, and the foundations are the medical and psychological assessment, the treatment of anything identified (thyroid, anaemia, sleep apnoea, hormonal, post-viral, cardiac, neurological, autoimmune, oncological, substance, medication), psychotherapy for the depressive disorders (CBT, IPT, behavioural activation, and others), and SSRI/SNRI where indicated. Sessions are typically 45 to 60 minutes; many clients and practitioners settle into a course of 3 to 6 weekly or fortnightly sessions to assess effect, often scheduled in the late afternoon or early evening so the relaxation effect can carry into the night, with periodic maintenance afterwards if it continues to be useful.
What the evidence says
A 2015 randomized sham-controlled trial of CST for anxiety and depression in 84 participants found statistically significant reductions in depression scores compared to sham at 8 weeks, and the effect was maintained at follow-up. The study authors described the effect as clinically meaningful. A 2023 meta-analysis also found positive effects for CST on anxiety and depression. However, this remains an area where more rigorous research is needed — some systematic reviews have criticized the overall evidence base.
Studies and reviews worth knowing for depression, low mood, and CST: the evidence base for the first-line treatments is strong and well replicated. The relevant psychotherapy meta-analysis is Cuijpers et al. 2014 (Journal of the Royal Society of Medicine, https://pubmed.ncbi.nlm.nih.gov/), a meta-analysis of more than 200 randomised trials of psychological treatments for adult depression, finding large effect sizes for CBT and interpersonal therapy versus waitlist and treatment-as-usual, and confirming that the combination of psychotherapy and antidepressant medication is more effective than either alone for moderate-to-severe MDD. The relevant antidepressant network meta-analysis is Cipriani et al. 2018 (The Lancet, PMID 29477251), comparing 21 antidepressants in head-to-head and placebo-controlled trials, with all 21 more effective than placebo and agomelatine, amitriptyline, escitalopram, mirtazapine, paroxetine, sertraline, and venlafaxine among the most effective and best tolerated. The UK NICE guideline for depression in adults (CG90, 2009, with a partial update in 2022) recommends a stepped-care model starting with recognition in primary care, low-intensity psychological interventions for subthreshold and mild depression, high-intensity psychological interventions (CBT, IPT) and/or an SSRI for moderate depression, and combined treatment for severe depression. The American Psychiatric Association 2019 practice guideline for the treatment of depression across three age groups (children, adults, older adults) provides comparable guidance with an initial focus on measurement-based care and on the choice of treatment according to severity, comorbidities, and patient preference. For CST specifically, there is no published randomised controlled trial of CST for any DSM-5 depressive disorder. The broader CST literature is reviewed in Jäkel & von Hauenschild 2019 (a narrative review of physiological and clinical effects of CST) and Haller et al. 2022 (a meta-analysis of RCTs of CST for chronic pain, with secondary outcomes including mood and quality of life; https://pubmed.ncbi.nlm.nih.gov/), which found significant short-term effects on pain intensity and disability across the included trials and noted consistent secondary improvements in mood and well-being. Two earlier fibromyalgia RCTs - Castro-Sánchez et al. 2011 (a randomised trial of CST versus sham/control in fibromyalgia patients) and Matarán-Peñarrocha et al. 2009 (a similar trial) - measured depression and anxiety as secondary outcomes and found significant reductions in the CST groups compared to sham. The honest read: CST is not supported by a condition-specific RCT for any depressive disorder; the indirect evidence from chronic-pain and fibromyalgia trials, the plausible mechanism via autonomic regulation, vagal tone, and chronic-tension release, and the consistent reports from individual clients that CST helps with some of the felt experience of low mood, justify its place as one optional complementary input alongside the evidence-based first-line treatments. None of that substitutes for the psychological and medical assessment or for psychotherapy and/or SSRI/SNRI where a depressive disorder is suspected, and the foundations remain the assessment, the treatment of any identified driver, and the evidence-based treatment for the depressive disorder itself. As with all conditions on this site, the evidence base continues to evolve and the next decade is likely to bring both clearer condition-specific CST trials and clearer comparative-effectiveness work against the psychological and pharmacological first-line treatments.
What to expect
A typical CST session for mood support lasts 45-60 minutes. The practitioner will use very light touch — usually on the head, base of skull, sacrum, and trunk. You remain fully clothed. Many people find CST deeply calming — some feel a release of emotions, others simply feel very relaxed. If you are currently in treatment for depression, do not stop or change your treatment plan without consulting your doctor.
Practical next steps if you are considering CST for low mood or alongside depression treatment: the medical and psychological assessment should be in motion first, not deferred, and CST - if it is going to be useful for you - sits alongside that work, not in place of it. A reasonable sequence, broadly: 1) Book a primary care appointment and ask for the standard workup that often accompanies low mood: thyroid panel (TSH, free T4, and where indicated free T3 and thyroid antibodies), full blood count and ferritin, B12 and folate, vitamin D, fasting glucose or HbA1c, a sleep history (and sleep-study referral if sleep apnoea is suspected), a medication and substance review (corticosteroids, interferon, beta-blockers, hormonal medications, isotretinoin, statins, PPIs, and others can all affect mood), and an honest discussion of alcohol, nicotine, cannabis, and other substance use. 2) Discuss with your primary care physician a referral to a mental health professional for a fuller assessment - the differential between MDD, persistent depressive disorder, bipolar depression, postnatal depression, perimenopausal depression, PMDD, seasonal affective disorder, adjustment disorder, and depression secondary to a medical condition is clinically important and the first-line treatment is different for each (mood stabilisers or atypical antipsychotics for bipolar, perinatal mental health services for postnatal, hormone therapy where indicated for perimenopausal, luteal-phase SSRI for PMDD, light therapy for seasonal, treating the underlying condition for secondary depression, and so on). 3) If a depressive disorder is identified, ask about psychotherapy first - CBT, IPT, and behavioural activation have the strongest evidence - and about an SSRI where indicated, with the expectation of 4 to 6 weeks to reach full effect and an honest discussion of side effects (initial increase in anxiety in some people, sexual side effects, sleep disturbance, weight change, and a black-box warning in under-25s about increased suicidal thoughts in the first weeks, which is why close follow-up at 1 to 2 weeks is standard). 4) Build the foundations alongside the treatment: regular sleep timing with adequate hours, daily movement in whatever form is sustainable (even 20 to 30 minutes of walking has measurable effect in the meta-analyses), reduced alcohol and stimulants, sunlight exposure in the morning, social contact maintained even when it does not feel like it, and a small set of meaningful activities kept in the week (behavioural activation is a real and effective intervention). 5) If CST is going to be part of the picture, choose a practitioner who takes the assessment seriously, who is comfortable working alongside psychotherapy and/or medication, and who will tell you honestly if what you are describing is outside the scope of what CST can help with. A reasonable trial of CST for the felt experience of low mood runs about 3 to 6 sessions within 6 to 8 weeks, often scheduled in the late afternoon or early evening so the relaxation effect can carry into the night. 6) Reassess at 6 to 8 weeks: if mood, energy, sleep, interest, and capacity to engage with the things that matter have not improved meaningfully, and the assessment, the foundations, and the psychotherapy and/or SSRI/SNRI where indicated are reasonably in place, escalate the conversation with your primary care physician and mental health professional. Options at that point include a fuller mental health reassessment, medication review (different SSRI/SNRI, augmentation with bupropion, mirtazapine, or an atypical antipsychotic, or a trial of ketamine/esketamine for treatment-resistant depression in specialist settings), evaluation for bipolar disorder if not yet considered, evaluation for post-viral syndromes including long COVID and ME/CFS, a thyroid recheck, a sleep review, a hormonal review, and a check of pain and autoimmune drivers. 7) If you are in crisis or having thoughts of self-harm, please contact a crisis line or emergency services straight away - the numbers are at the bottom of this page. None of this means CST did not help; it reflects that low mood and depression are symptoms with many possible drivers, and the work is to find and address the real ones. As with all condition pages on this site, please consult your physician or mental health professional before starting any new therapy, including CST, especially if you have a current diagnosis, are taking medication, or are in active treatment for depression.
Frequently asked questions
Can CST treat clinical depression?
+
Can CST treat clinical depression?
+No — clinical depression requires evidence-based treatment (psychotherapy, medication, or both). CST is not a treatment for depression. However, it may be a supportive complementary therapy for some people alongside conventional treatment.
Is CST safe to use alongside antidepressants?
+
Is CST safe to use alongside antidepressants?
+Yes — CST involves only very light touch and has no known pharmacological interactions. Always inform your practitioner of any medications you are taking. Do not adjust your medication without consulting your doctor.
How does CST affect the nervous system in depression?
+
How does CST affect the nervous system in depression?
+CST aims to support parasympathetic (rest-and-recover) nervous system states. Some people with depression have a chronically activated stress response. By reducing overall physiological stress and supporting nervous system regulation, CST may contribute to a more regulated baseline state.
Can I use CST instead of therapy for depression?
+
Can I use CST instead of therapy for depression?
+No — CST is not a substitute for evidence-based mental health treatment. If you are experiencing depression, please consult a doctor or mental health professional to discuss evidence-based options.
When should I see a doctor first?
+
When should I see a doctor first?
+When to seek medical care first: Craniosacral therapy is a gentle, complementary approach, but it should not replace urgent medical assessment. See a physician promptly if you have any of the following: sudden severe pain unlike anything you've had before; new neurological symptoms (numbness, weakness, vision changes, slurred speech, severe dizziness or balance loss); fever, chills, or other signs of infection; unexplained weight loss; blood in stool, urine, or vomit; new or changing lumps or masses; severe headache with fever, stiff neck, or rash; recent trauma to the head, neck, or spine; pregnancy complications; severe shortness of breath or chest pain; thoughts of self-harm. Trained CST practitioners screen for these and will refer you when needed. Always tell your practitioner about any current or recent medical conditions, pregnancy, medications, blood thinners, recent surgery, cancer history, or implanted devices.
Is 'depression' or 'low mood' a real medical diagnosis, and if not, what is?
+
Is 'depression' or 'low mood' a real medical diagnosis, and if not, what is?
+Not exactly. The everyday words 'depression' and 'low mood' are not themselves diagnostic terms. The real diagnostic entities are the depressive disorders as classified by DSM-5-TR and ICD-11: major depressive disorder (MDD, characterised by at least two weeks of persistent low mood or anhedonia plus associated symptoms across sleep, appetite, energy, concentration, psychomotor activity, self-worth, and suicidality), persistent depressive disorder (dysthymia, a chronic lower-grade form lasting two or more years), the bipolar and related disorders (depressive episodes in bipolar I and bipolar II, with the critical differential of whether there is a history of mania or hypomania), perimenopausal and postnatal depression (each with specific guidelines - NICE NG222 and NICE CG192), premenstrual dysphoric disorder (PMDD), seasonal affective disorder, depression with psychotic features (which needs specialist care, not a CST session), and the adjustment disorders with depressed mood. The first-line evidence-based treatments for the depressive disorders are psychotherapy (CBT, IPT, behavioural activation) and antidepressant medication (SSRIs are the usual first-line pharmacological choice, with SNRIs, mirtazapine, bupropion, and others where indicated). For moderate-to-severe MDD the combination of CBT and an SSRI is more effective than either alone. Craniosacral therapy is not a first-line treatment for any depressive disorder and is not a substitute for the diagnostic assessment, the psychological work, or the medication where indicated. A CST practitioner who notices features consistent with a depressive disorder should help you find the right workup rather than positioning CST as the treatment for the condition.
How does CST differ from CBT and SSRI/SNRI for depression?
+
How does CST differ from CBT and SSRI/SNRI for depression?
+CBT and SSRI/SNRI are the first-line evidence-based treatments for the depressive disorders. CBT is a structured psychological treatment - typically 8 to 16 weekly sessions of cognitive restructuring, behavioural activation, problem-solving, and (for some presentations) interpersonal work - with large effect sizes in the major meta-analyses (Cuijpers 2014, with hundreds of trials confirming the benefit of CBT and IPT). SSRI/SNRI medications (sertraline, escitalopram, citalopram, fluoxetine, paroxetine, venlafaxine, duloxetine) take 4 to 6 weeks to reach full effect, with a useful but not always well-tolerated early period. For moderate-to-severe MDD, the combination of CBT and an SSRI is more effective than either alone. CST is a complementary manual approach that works with the cranial and fascial structures and with autonomic regulation, with very light contact. There is no published RCT of CST for any DSM-5 depressive disorder specifically, but CST trials for other conditions (notably fibromyalgia - Castro-Sánchez 2011, Matarán-Peñarrocha 2009) have measured depression as a secondary outcome and found reductions. The two are not rivals: most people with a diagnosable depressive disorder will benefit most from psychotherapy and/or SSRI/SNRI, with CST as one gentle complementary input alongside the evidence-based treatment for some of the underlying drivers of the felt experience of low mood - overactive autonomic arousal in some patterns and a heavy low-arousal shutdown in others, chronic muscle tension, shallow breathing, disrupted sleep-wake cycles, and difficulty resting.
Should I do CST before or after my depression assessment?
+
Should I do CST before or after my depression assessment?
+Both is fine in terms of timing, but the medical and psychological assessment should be in motion, not deferred. There is no harm in starting CST while your primary care physician runs the standard panel (thyroid, ferritin, B12, sleep history, medication review) and you begin exploring a referral to a mental health professional for a fuller assessment, and many people do. The thing to avoid is using CST as a reason to delay the assessment, or to position CST as the answer before the real drivers and any depressive disorder have been identified. A reasonable framing: book the medical and mental health appointments first or alongside the first CST session, ask about psychotherapy (CBT, IPT, behavioural activation) and/or SSRI/SNRI if a depressive disorder is suspected, and give both 4 to 8 weeks. If the assessment identifies a treatable driver (thyroid, anaemia, B12, sleep apnoea, cardiac, neurological, autoimmune, oncological, hormonal, post-viral, medication, substance), treat that driver; CST sits alongside the treatment, not in place of it. If psychotherapy is recommended, complete the course; if SSRI/SNRI is recommended and well tolerated, give it the 4 to 6 weeks to reach full effect; CST, if it helps, is a complement to that work, not a substitute for it. If you have a history of mania or hypomania and a depressive episode, this changes the differential to a bipolar disorder and the treatment approach is different - mention this to your physician and mental health professional before starting an SSRI, because antidepressants used alone in bipolar depression can trigger a manic episode.
Can CST help if my low mood is caused by thyroid, hormonal, post-natal, or post-viral issues?
+
Can CST help if my low mood is caused by thyroid, hormonal, post-natal, or post-viral issues?
+Only as a complement to the specific treatment, never as a substitute. Hypothyroidism and hyperthyroidism need a thyroid panel and endocrine review; specific treatments (levothyroxine for hypothyroidism; antithyroid medication, radioactive iodine, or surgery for hyperthyroidism) usually resolve the mood features. Postnatal depression needs a perinatal mental health review and the right treatment (psychotherapy, SSRI, and for some women specialist perinatal services) - the earlier the assessment, the better the outcome for both mother and baby. Perimenopausal depression needs a gynaecological and mental health review and the right treatment (hormone replacement therapy where indicated, CBT, and SSRI/SNRI). PMDD has its own specific treatment (SSRI daily or in the luteal phase, hormonal suppression in some cases). Post-viral fatigue and new low mood lasting more than 4 to 6 weeks after a confirmed or suspected infection, especially with post-exertional symptom worsening, are worth evaluating for post-viral syndromes including long COVID and ME/CFS - the management is specific (pacing, sleep, careful return to activity, treatment of orthostatic intolerance and other features), and CST can sit alongside as one gentle input for some of the felt experience but does not replace the specific management. The pattern across all of these is the same: identify the real driver, treat the driver with the right intervention, and use CST - if at all - as one gentle complementary input that some people find helpful for the autonomic dysregulation, muscle tension, shallow breathing, sleep disturbance, and felt sense of heaviness that often accompany these conditions.
What should I do if CST does not improve my low mood?
+
What should I do if CST does not improve my low mood?
+Tell the practitioner, and go back to your primary care physician (or your mental health professional) for a reassessment. Honest CST practitioners welcome the conversation. A reasonable trial of CST for the felt experience of low mood runs about 3 to 6 sessions within 6 to 8 weeks, often scheduled in the late afternoon or early evening so the relaxation effect can carry into the night. If you do not notice meaningful improvement in mood, energy, sleep, interest, capacity to engage with the things that matter, and the felt sense of connection by that point - and especially if the foundations (sleep, caffeine, alcohol, movement) and the medical and psychological assessment and psychotherapy and/or SSRI/SNRI where indicated are reasonably in place - escalate the conversation. Options your physician or mental health professional may then consider include a fuller mental health reassessment, medication review (different SSRI/SNRI, augmentation with bupropion, mirtazapine, or an atypical antipsychotic, or a trial of ketamine/esketamine for treatment-resistant depression in specialist settings), evaluation for bipolar disorder if not yet considered (this is the most commonly missed mood-disorder differential and changes the first-line treatment), a thyroid recheck, a sleep review, a hormonal review, evaluation for post-viral syndromes including long COVID and ME/CFS, a cardiac or neurological review if not already done, a check of autoimmune and oncological drivers, and a substance use review. If you are in crisis or having thoughts of self-harm at any point, please contact a crisis line or emergency services straight away - the numbers are at the bottom of this page. None of this means CST did not help; it reflects that low mood and depression are symptoms with many possible drivers, and the work is to find and address the real ones.